GlassScriptPhysician profile
Susan Vogel
NPI 1316925027
$2,808.50
in general payments reported to CMS, 2019-2025
16 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $318 · 2021: $266 · 2022: $285 · 2023: $526 · 2024: $366 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,340.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $997.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $512.41 | 2019-2025 | Otezla, Repatha, Krystexxa |
| Astrazeneca Pharmaceuticals LP | $376.02 | 2019-2024 | Farxiga |
| Medtronic, INC. | $139.16 | 2021-2022 | |
| Amarin Pharma, INC. | $134.44 | 2019-2020 | |
| Exact Sciences Corporation | $118.58 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $106.99 | 2019-2025 | |
| Paratek Pharmaceuticals, INC. | $105.58 | 2023 | Nuzyra |
| Abbvie INC. | $102.60 | 2023 | Dalvance |
| Lilly USA, LLC | $47.57 | 2021-2025 | Zepbound, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.53 | 2022-2025 | Xifaxan |
| Dexcom, INC. | $31.82 | 2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.74 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $23.71 | 2025 | Givlaari |
| Arbor Pharmaceuticals, INC. | $22.59 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Vogel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.